Skip to content

Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis

Pharyngeal Electrical Stimulation in Amyotrophic Lateral Sclerosis: A Pilot Study With 20 Patients

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03481348
Enrollment
20
Registered
2018-03-29
Start date
2018-02-01
Completion date
2020-07-21
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Amyotrophic Lateral Sclerosis

Brief summary

During the course of ALS most patients develop swallowing deficits. In this pilot study we investigate if dysphagia in ALS can be improved by Pharyngeal Electrical Stimulation (PES). PES is Communauté Européenne (CE-) certificated and has been approved for treatment of neurological, oropharyngeal dysphagia. During PES, electrical stimuli are applied at the pharynx via a nasogastral tube with the aim of triggering reorganization processes in damaged brain structures. There is evidence of a positive effect of PES in Stroke and Multiple Sclerosis patients.

Interventions

Pharyngeal Electrical Stimulation is applied at the pharynx via a nasogastral tube for 10 minutes per day on 3 consecutive days.

Sponsors

University of Ulm
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* possible, probable or definite ALS according to the revised El Escorial criteria (Brooks et al. 2000) * age \>18 years * able to understand all information and to give full consent according to good clinical practice (GCP) * moderate ot severe dysphagia, defined by a mean value (all consistencies) of 4

Exclusion criteria

* concurrent participation in another interventional trial * tracheostomy * severe psychiatric disorder or clinically manifest dementia * pulmonal or cardial disorder which constitutes a risk when inserting the tube into the pharynx * permanent cardiac pacemaker or defibrillator

Design outcomes

Primary

MeasureTime frameDescription
Penetration Aspiration Scale (PAS) Scoreday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90Degree of Penetration and Aspiration evaluated by fiberendoscopic evaluation of swallowing (FEES)

Secondary

MeasureTime frameDescription
Schluckbeeinträchtigungs-Skala (SBS) Scoreday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90Clinical scale to evaluate severity of dysphagia
Functional Oral Intake Scale (FOIS) Scoreday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90Clinical scale to evaluate the impairment of oral food intake
Swallowing-Quality of Life Score (SWAL-QOL)day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90swallowing-specific quality of life questionnaire
Amyotrophic Lateral Sclerosis Functional Rating Scale Revised (ALS-FRS-R)day 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90Clinical scale to evaluate the severity of symptoms in ALS
Frequency of Adverse Eventsday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90Frequency of Adverse Events
Dysphagia Severity Rating Scale (DSRS) Scoreday 0 (=before PES), day 4 (=after PES), day 7, day 21, day 90Clinical scale to evaluate severity of dysphagia

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026